Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Pulse Biosciences Inc PLSE

Healthcare Medical Devices
Pulse Biosciences, Inc. is a bioelectric medicine company. The Company’s proprietary CellFX nsPFA technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent noncellular tissue. The Company is engaged in the development of its CellFX nsPFA technology for use in the treatment of atrial fibrillation and in a select few other markets where it... see more

Recent & Breaking News (NDAQ:PLSE)

Pulse Biosciences Announces $30 Million Private Placement

Business Wire September 25, 2017

12 Biggest Mid-Day Losers For Wednesday

Benzinga.com  September 13, 2017

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Tintri, Inc. -- TNTR

Business Wire September 11, 2017

Glancy Prongay & Murray LLP Commences Investigation on Behalf of Pulse Biosciences, Inc. Investors (PLSE)

Business Wire September 11, 2017

Mid-Day Market Update: Dow Up 1%; Achillion Pharmaceuticals Shares Plunge

Benzinga.com  September 11, 2017

EQUITY ALERT: Rosen Law Firm Announces Investigation of Securities Claims Against Health Insurance Innovations, Inc. – HIIQ

Business Wire September 11, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Tintri, Inc. (TNTR)

PR Newswire September 11, 2017

Pulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTxTM System

Business Wire September 11, 2017

Pulse Biosciences Quarterly Investor and Analyst Conference Call

Business Wire July 27, 2017

Investor Network: Pulse Biosciences, Inc. to Host Earnings Call

Accesswire July 27, 2017

Pulse Biosciences Announces Treatment of First Patient in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation Technology for Seborrheic Keratosis Lesions

Business Wire June 6, 2017

Kerrisdale Capital Issues Negative Report on Pulse Biosciences, Inc. and Announces Conference Call

PR Newswire May 9, 2017

Pulse Biosciences Quarterly Investor Conference Call

Business Wire May 4, 2017

Investor Network: Pulse Biosciences, Inc. to Host Earnings Call

Accesswire May 4, 2017

Pulse Biosciences to Host Quarterly Investor Conference Call on May 4, 2017

Business Wire April 17, 2017

Pulse Biosciences Quartery Investor Conference Call

Business Wire March 14, 2017

Pulse Biosciences Submits 510(k) Application to FDA for PulseTx™ System

Business Wire March 14, 2017

Pulse Biosciences to Host Investor Conference Call on March 14, 2017

Business Wire March 1, 2017

Pulse Biosciences Announces Healthcare Executives and Entrepreneurs Robert Duggan and Dr. Maky Zanganeh Have Acquired a Combined Interest of 17.1% of the Company

Business Wire February 10, 2017

Pulse Biosciences Quarterly Nano-Pulse Stimulation (NPS) Update

Business Wire November 14, 2016